Zoetis Inc at JPMorgan Healthcare Conference Transcript | | StockXpo

Try Stockxpo Premium

Zoetis Inc at JPMorgan Healthcare Conference Transcript

Published: Tuesday, January 23, 2024 · 6:33 AM  |  Updated: Tuesday, January 23, 2024 · 6:33 AM

📊 687 views

SHARE











Jan 08, 2024 / 11:45PM GMT
Christopher Thomas Schott – JPMorgan Chase & Co, Research Division – Senior Analyst

Good afternoon, everybody. I’m Chris Schott at JPMorgan, and it’s my pleasure to be introducing Zoetis today. From the company, we’ll have a presentation from Kristin Peck, CEO, and then we’ll go to a Q&A session after that. Obviously, a lot of exciting things going on at Zoetis, including the recent Librela launch, and we’ll hear more about that. But let me turn this over to Kristin, and thanks for joining us.

Kristin C. Peck – Zoetis Inc. – CEO & Director

Hello, everyone. It is great to be back. Thank you, Chris, for the introduction, to share a little bit about Zoetis. But I don’t think it would be a presentation at the JPMorgan conference if you didn’t have the legal disclaimer of forward-looking statements and non-GAAP financials, which you can find the more information on these risks and the reconciliations in the deck we posted on our website as well as in all of our SEC filings. So with that said, let’s get started.

Let me share a little bit about what

MORE IN INSIDE INVESTMENT NEWS

scroll to top